GLO Pharma adds Marla Beck to its Board of Directors

– USA, NY –  GLO Pharma today announced the appointment of Marla Beck to its Board of Directors, effective immediately, expanding the Board to seven members, of which five are women.

Her appointment adds a new seat to the GLO Pharma board, which now consists of, and is led by Chairman Scott L. Glenn.

About Marla Beck

Marla Beck is the co-founder and former CEO of the leading luxury beauty retailer Bluemercury. Mais. Beck is a serial entrepreneur and visionary brand-builder who is highly experienced in building and scaling mission-driven consumer brands. As a founder and CEO, she is known for leading rapid and transformative growth and building enduring and authentic brands predominantly centered around innovation, empowerment, transparency, and sustainability.

Ms. Beck co-founded Bluemercury, a high-growth, disruptive omnichannel beauty retailer, in 1999 and, as CEO, led its acquisition by Macy’s Inc. (NYSE: M) in 2015. Following the acquisition, she continued to serve as CEO of a division of Macy’s until 2021, where she was responsible for all aspects of operations, including digital strategies, marketing, merchandising, loyalty programming, real estate, store expansion and development, finance, and human resources across 180+ locations and 27 states. She is also the co-founder of M-61 Laboratories, the creator of clean, sustainable beauty brands M-61 Powerful Skincare and Lune+Aster Cosmetics. Before founding Bluemercury, she was a consultant at McKinsey & Company.

“Marla has always been a trailblazer and ahead of her time in innovation around the consumer experience, brands, and products. During the 22 years she was at Bluemercury she launched hundreds of brands and thousands of products. She created and launched over 300 skincare and makeup products for the beauty brands she founded and she has supported a multitude of brand founders as they launched their brands at Bluemercury. She clearly understands what it takes for a brand to truly differentiate itself in a crowded market,” says Chairman Scott Glenn. “Beyond this, she is a true visionary who can see a brand’s potential for expansion across both product categories and all facets of retail. We couldn’t be more thrilled to have her in our corner as a member of our Board.”

About GLO Pharma

GLO Pharma is a biotechnology company dedicated to developing innovative approaches to beauty and aesthetics. It was founded in 2018 by Scott Glenn and Lauren Otsuki, innovators within the biotechnology space for over 20 years. Mr. Glenn and Ms. Otsuki previously founded and developed professional skincare companies Alastin Skincare and SkinMedica, along with numerous pharmaceutical companies aimed at solving some of the toughest medical issues in infertility, diabetes, cardiovascular disease, and cancer. In 2022, GLO Pharma launched its first consumer brand, Ourself, as the first-ever Subtopical Skincare System, bridging the gap between traditional skincare products and clinical procedures.

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.